Corporate$NRXP7:00 AM ETdeveloping · v2

NRx Pharmaceuticals receives FDA approval for Preservative-Free Ketamine

By BORSA NewsroomPublished Oct 30, 2026, 7:00 AM EDTUpdated Oct 30, 2026, 7:01 AM EDT

FDA approved NRx's ANDA for Preservative-Free Ketamine ahead of the November 10 goal date. The product is an American-manufactured ketamine without benzethonium chloride, addressing drug shortages.

Sentimentbullish 85

Strongly bullish · 85 of 100

Impact70

medium · sector-wide

Confidence95%

high confidence · 2 wires

Eventdeveloping

v2 · alerted as breaking

WHAT WE KNOW

FDA approved NRx's ANDA for Preservative-Free Ketamine
Approval date: October 30, 2026, ahead of November 10 goal date